相关实验视频
Updated: May 28, 2025
05:53
Use of a Hanging-weight System for Liver Ischemia in Mice
Published on: August 7, 2012
15.9K
肝激素及其在心肝相互作用中的作用在心力衰竭中
Wael A Shouman1, Sarah Najmeddine1, Lilas Sinno1
1Department of Pharmacology and Toxicology, American University of Beirut Faculty of Medicine, Beirut, Lebanon.
European journal of pharmacology
|February 8, 2025
概括
肝素,来自肝脏的蛋白质,越来越多地被认为是它们在心力衰竭中的作用. 了解这些因素对于改善患者的治疗结果和开发新疗法至关重要.
科学领域:
- 心血管医学 心血管医学
- 肝病学 肝病学是一种肝病学.
- 代谢调节 代谢调节 代谢调节
背景情况:
- 心力衰竭是影响多个器官系统的全球健康危机.
- 肝脏在心力衰竭的发病过程中发挥着重要作用,如心脏肝病和肝硬化性心肌病等疾病与预后不佳有关.
- 关于肝细胞衍生蛋白和代谢调节剂对心力衰竭进展和相关并发症的影响,现有的知识缺口存在.
研究的目的:
- 为了确定关键的肝激素 (adropin, fetuin-A, fetuin-B, FGF-21, selenoprotein P, α1-microglobulin) 涉及到心力衰竭.
- 探索这些肝激素作为代谢平衡和心脏功能障碍调节者的作用.
- 综合当前关于肝因参与不良心脏重塑,纤维化,缓冲症和功能障碍的研究.
主要方法:
- 关于研究肝因在心力衰竭中的研究的文献综述.
- 分析 hepatokines 影响细胞过程的拟议机制.
- 鉴定正在调查的特定肝因,以确定它们在心脏功能障碍中的作用.
主要成果:
- 一些肝激素,包括adropin, fetuin-A, fetuin-B,FGF-21,蛋白P和α1-微球蛋白,正在研究它们对心力衰竭的影响.
- 这些因素被建议调节关键路径,如氧化应激,纤维化,亡,炎症和线粒体功能.
- 新出现的证据表明,在心力衰竭的背景下,它们对免疫反应,细胞迁移和整体代谢平衡的影响.
结论:
- 肝激素是理解和潜在治疗心力衰竭的重要研究领域.
- 需要进一步研究这些肝脏衍生因素的确切作用和临床应用.
- 向肝激素可能为管理心力衰竭及其并发症提供新的治疗策略.
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:22Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
374
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
374
01:26Heart Failure Drugs: Inotropic Agents
504
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
504
01:16Hepatic Drug Excretion: Influencing Factors
78
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
78
01:30Liver Physiology
412
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
412